Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms

BACKGROUND: Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms. However, previous results on the efficacy of repeated administrations of oxytocin are controversial. Recently, we reported time-course changes in the efficacy of the neuropeptide underlyin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Autism
Autors principals: Kato, Yasuhiko, Kuwabara, Hitoshi, Okada, Takashi, Munesue, Toshio, Benner, Seico, Kuroda, Miho, Kojima, Masaki, Yassin, Walid, Eriguchi, Yosuke, Kameno, Yosuke, Murayama, Chihiro, Nishimura, Tomoko, Tsuchiya, Kenji, Kasai, Kiyoto, Ozaki, Norio, Kosaka, Hirotaka, Yamasue, Hidenori
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903697/
https://ncbi.nlm.nih.gov/pubmed/33622389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13229-021-00423-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars